Predictive Value of Blood Interleukin-6 Level in Patients with Acute Coronary Syndrome: A Meta-analysis.
CONCLUSION: Increased blood level of interleukin-6may be independently associated with higher risk of MACE, cardiovascular and all-cause mortality in patients with ACS. Measurement of blood interleukin-6 level has potential to improve risk stratification of ACS.
PMID: 32811241 [PubMed - as supplied by publisher]
Source: Immunological Investigations - Category: Allergy & Immunology Tags: Immunol Invest Source Type: research
More News: Allergy & Immunology | Arrhythmia | Cancer & Oncology | Cardiology | Cardiovascular | Databases & Libraries | Heart | Heart Failure | Stroke | Study